|
Volumn 105, Issue 18, 2002, Pages 2212-2216
|
Mineralocorticoid receptor antagonism in experimental atherosclerosis
|
Author keywords
Atherosclerosis; Endothelium; Nitric oxide; Superoxide
|
Indexed keywords
ACETYLCHOLINE;
ALDOSTERONE;
CHOLESTEROL;
EPLERENONE;
MINERALOCORTICOID RECEPTOR;
REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE;
REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;
SUPEROXIDE;
ALDOSTERONE BLOOD LEVEL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
AORTA;
ARTICLE;
ATHEROSCLEROSIS;
BLOOD VESSEL REACTIVITY;
CELL FUNCTION;
CONTROLLED STUDY;
ENDOTHELIUM;
ENZYME ACTIVITY;
FAT INTAKE;
HYPERLIPIDEMIA;
MALE;
NONHUMAN;
PHARMACOLOGICAL BLOCKING;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
RABBIT;
RADIOIMMUNOASSAY;
RECEPTOR BLOCKING;
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
TREATMENT OUTCOME;
ALDOSTERONE ANTAGONISTS;
ANIMALS;
AORTA;
ARTERIOSCLEROSIS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ENDOTHELIUM, VASCULAR;
MALE;
MULTIENZYME COMPLEXES;
NADH, NADPH OXIDOREDUCTASES;
NADPH OXIDASE;
ORGAN CULTURE TECHNIQUES;
RABBITS;
RECEPTORS, ALDOSTERONE;
RNA, MESSENGER;
SIGNAL TRANSDUCTION;
SPIRONOLACTONE;
SUPEROXIDES;
VASOMOTOR SYSTEM;
|
EID: 0037035471
PISSN: 00097322
EISSN: None
Source Type: Journal
DOI: 10.1161/01.CIR.0000015854.60710.10 Document Type: Article |
Times cited : (203)
|
References (12)
|